Cargando…

Mast cell activation is associated with post‐acute COVID‐19 syndrome

Detalles Bibliográficos
Autores principales:	Wechsler, Joshua B., Butuci, Melina, Wong, Alan, Kamboj, Amol P., Youngblood, Bradford A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2021
Materias:	Letters
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9299596/ https://www.ncbi.nlm.nih.gov/pubmed/34820848 http://dx.doi.org/10.1111/all.15188

Ejemplares similares

Mast Cell and Eosinophil Activation Are Associated With COVID-19 and TLR-Mediated Viral Inflammation: Implications for an Anti-Siglec-8 Antibody
por: Gebremeskel, Simon, et al.
Publicado: (2021)

A monoclonal antibody to Siglec-8 suppresses non-allergic airway inflammation and inhibits IgE-independent mast cell activation
por: Schanin, Julia, et al.
Publicado: (2020)

Famotidine: A potential mitigator of mast cell activation in post-COVID-19 cognitive impairment
por: Kow, Chia Siang, et al.
Publicado: (2023)

Functional and Phenotypic Characterization of Siglec-6 on Human Mast Cells
por: Robida, Piper A., et al.
Publicado: (2022)

Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome
por: Afrin, Lawrence B., et al.
Publicado: (2020)

Discovery of an agonistic Siglec-6 antibody that inhibits and reduces human mast cells
por: Schanin, Julia, et al.
Publicado: (2022)

The Inhibitory Receptor Siglec-8 Interacts With FcεRI and Globally Inhibits Intracellular Signaling in Primary Mast Cells Upon Activation
por: Korver, Wouter, et al.
Publicado: (2022)

Comparing histamine intolerance and non-clonal mast cell activation syndrome
por: Cimolai, Nevio
Publicado: (2020)

Mast cells in lung damage of COVID‐19 autopsies: A descriptive study
por: Schaller, Tina, et al.
Publicado: (2022)

Safety of COVID‐19 vaccination in children with prior allergic reactions or mast cell disorders
por: Kulkarni, Rishabh, et al.
Publicado: (2023)

Hyperactivated Mast Cells Pathogenesis Hypothesis for COVID-19 Cutaneous Manifestations
por: Ricke, Darrell O.
Publicado: (2021)

Into the looking glass: Post-viral syndrome post COVID-19
por: Perrin, Ray, et al.
Publicado: (2020)

Anosmia as a predictor for post-COVID-19 fatigue syndrome
por: Wostyn, Peter
Publicado: (2021)

Mast cell activation syndrome
por: Ratner, Vicki
Publicado: (2015)

Acute tubulointerstitial nephritis with or without uveitis: a novel form of post-acute COVID-19 syndrome in children
por: Avramescu, Marina, et al.
Publicado: (2023)

Post Covid-19 Guillain Barre Syndrome
por: Maramattom, Boby Varkey, et al.
Publicado: (2021)

Post-COVID-19 Tachycardia Syndrome: A Distinct Phenotype of Post-Acute COVID-19 Syndrome
por: Ståhlberg, Marcus, et al.
Publicado: (2021)

Association Between Visceral Hypersensitivity in Irritable Bowel Syndrome, Intestinal Microbiota, and Mast Cells: How to Detect Mast Cells Using Confocal Microscopy
por: Lee, Kang Nyeong, et al.
Publicado: (2021)

Post-HPV-Vaccination Mast Cell Activation Syndrome: Possible Vaccine-Triggered Escalation of Undiagnosed Pre-Existing Mast Cell Disease?
por: Afrin, Lawrence B., et al.
Publicado: (2022)

Understanding COVID-19 Acute Respiratory Distress Syndrome
por: Singh, Anchit Raj, et al.
Publicado: (2022)

Safety of COVID-19 vaccination in patients with mastocytosis and monoclonal mast cell activation syndrome
por: Kaakati, Rayan, et al.
Publicado: (2021)

Post-acute COVID-19 syndrome presented as a cerebral and systemic vasculitis: a case report
por: Ivanovic, Jovana, et al.
Publicado: (2022)

Immunological dysfunction and mast cell activation syndrome in long COVID
por: Sumantri, Stevent, et al.
Publicado: (2023)

Tubulointerstitial nephritis and uveitis syndrome post‐COVID‐19
por: Maggio, Maria Cristina, et al.
Publicado: (2023)

Post COVID-19 Acute Myocardial Infarction Rebound
por: Fardman, Alexander, et al.
Publicado: (2020)

Correspondence: Neuropsychiatric post-acute sequelae of COVID-19
por: Kleebayoon, Amnuay, et al.
Publicado: (2023)

Potential prophylactic efficacy of mast cell stabilizers against COVID-19 vaccine-induced anaphylaxis
por: Kazama, Itsuro
Publicado: (2021)

Immunoglobulin signature predicts risk of post-acute COVID-19 syndrome
por: Cervia, Carlo, et al.
Publicado: (2022)

Post-acute COVID-19 syndrome
por: Montani, David, et al.
Publicado: (2022)

Molnupiravir and nirmatrelvir–ritonavir reduce mortality risk during post-acute COVID-19 phase()
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

The Impact of Acute Illness Severity on Post–COVID-19 Sequelae Remains an Unsettled Question
por: Konstantinidis, Ioannis, et al.
Publicado: (2021)

Asthma in COVID-19 Hospitalizations: An Overestimated Risk Factor?
por: Broadhurst, Richard, et al.
Publicado: (2020)

Post-COVID syndrome: Turning convalescence into illness?
por: Cozzi, Giorgio, et al.
Publicado: (2021)

Post COVID 19 multisystem inflammatory syndrome in an older adult
por: Parpas, Alexander, et al.
Publicado: (2021)

Low prevalence of post-COVID-19 syndrome in patients with asthma
por: Garcia-Pachon, Eduardo, et al.
Publicado: (2021)

Post-intensive care syndrome in patients surviving COVID-19
por: Daste, Camille, et al.
Publicado: (2021)

Use of Corticosteroid in Persistent Post–COVID-19 Interstitial Lung Disease
por: Khaw, Chuen R., et al.
Publicado: (2021)

The effect of molnupiravir on post-acute outcome of COVID-19 survivors
por: Hsu, Wan-Hsuan, et al.
Publicado: (2023)

Any Defining Role of Mast Cell or Mast Cell Density in Oral Squamous Cell Carcinoma?
por: Özdemir, Ö
Publicado: (2014)

Alcohol Consumption and the Risk of Acute Respiratory Distress Syndrome in COVID-19
por: Lassen, Mats Christian Højbjerg, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_ct1sm92n29kij45kojp76mr7mu